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Surveillance of a coiled renal artery aneurysm by
contrast-enhanced ultrasound with Definity
Gavin Low, MBChB, MRCS, FRCR, Sean D. Winters, MD, FRCPC, and
Richard J. T. Owen, MB BCh, MRCP, FRCR, Edmonton, Alberta, Canada
Imaging surveillance is necessary to assess for long-term procedural outcomes after endovascular treatment. This is
generally performed by computed tomography (CT) or magnetic resonance imaging (MRI). Contrast-enhanced ultra-
sound (CEUS) has recognized utility for cardiovascular and abdominal applications and is an alternative option in
patients with renal impairment or CT/MR contrast-related reactions. We believe that we present the first reported case
of CEUS in the surveillance of a treated renal artery aneurysm. The 57-year-old patient had a severe CT contrast allergy.
CEUS performed with Definity microbubble ultrasound contrast (Lantheus Medical Imaging, Billerica, Mass) was well
tolerated and showed no residual filling of the aneurysm. (J Vasc Surg 2011;54:1801-4.)
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DEndovascular techniques have been developed as a
minimally invasive alternative to surgery for the treatment
of renal artery aneurysms.1,2 While the short-term success
rates of these techniques are satisfactory, long-term results
remain unclear and periodic imaging surveillance is essen-
tial. This is generally performed by computed tomography
(CT) or magnetic resonance imaging (MRI). Where this is
not appropriate, alternative imaging options such as con-
trast-enhanced ultrasound (CEUS) must be considered.
CEUS has superior accuracy compared to a standard ultra-
sound scan with diagnostic performance similar to a CT
and MRI.3-6 Two large reviews found that the diagnostic
accuracy of CEUS in patients with pathologic confirmation
was identical at 89% and that CEUS was associated with a
general reduction in time to diagnosis, reduction in referral
for CT, MRI, or both; and a positive contribution to
patient management in 17.5% and 15.6%, respectively.5,6
Vascular indications for CEUS include the assessment of
vessel patency, stenosis or occlusions, and aortic stent graft
surveillance. However, to our knowledge, we present the
first reported case of use of CEUS for the surveillance of a
coiled renal artery aneurysm.
CASE REPORT
A CEUS scan was performed on a 57-year-old female patient
for the surveillance of a treated renal artery aneurysm. Six months
previously, the patient had undergone endovascular treatment
with Gugliemi detachable coils (GDCs; Boston Scientific, Natick,
Mass) coil embolization of a 1.5-cm saccular aneurysm of the left
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DC was used as a parenchymal sparing technique. Immediate
ostprocedure angiographic images and 3-month follow-up con-
rast-enhanced CT showed vascular exclusion of the aneurysm (Fig
). The patient, however, had a history of severe allergy to iodin-
ted contrast media. For the coiling and follow-up CT, this had
een successfully managed with premedication using steroids,
ntihistamines, and prolonged in-hospital observation. In order to
educe both risk and inconvenience to the patient, an alternate
maging modality was sought. An MRI was felt to have significant
imitations in this context due to a combination of decreased spatial
esolution and metallic artifact, which would obscure aneurysm
eck detail. CEUS was favored as the diagnostic option of choice
or future surveillance.
A 6-month surveillance CEUS was performed with Definity
erflutren Lipid Microsphere (Lantheus Medical Imaging, Bil-
erica, Mass). Precontrast standard grayscale ultrasound scan
howed the aneurysm as a focal area obscured by dense shadowing
rom the coil material (Fig 2). Color Doppler ultrasound was not
ble to evaluate flow within the aneurysm due to artifact from the
DCs. Following a 1-mL intravenous injection of Definity, CEUS
as performed utilizing low mechanical index contrast-specific
oftware. This showed absence of flow within the aneurysm, pa-
ency of the main renal artery and its branches, and normal renal
arenchymal perfusion (Fig 3).
ISCUSSION
Ultrasound contrast agents comprise small micro-
ubbles (2-6 m in size) composed of a biocompatible
uter shell and an inert filling gas of low solubility. These
urely intravascular agents behave as blood pool tracers
agnifying the returning echo signal by 500 to 1000 times
ompared to standard ultrasound scan and displaying flow
n large and medium-sized vessels and in the parenchymal
icrovasculature.7,8 Ultrasound scan contrast agents work
y amplification of ultrasound backscatter as a result of
onlinear microbubble oscillation and disruption.8 As a
esult of this phenomenon, CEUS offers superior diagnos-
ic performance compared to standard ultrasound and color
oppler scan.3-6 CEUS is also useful for converting non-
iagnostic standard ultrasound scan cases to diagnostic
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December 20111802 Low et alstudies on CEUS.3-6 Similarly, CEUS is used as a “Doppler
rescue” technique in cases that are nondiagnostic on color
Doppler scan.9,10 Contrast agents such as Definity are
stable in the blood pool for 3 to 5 minutes at low mechan-
ical index (0.1) settings. Used with contrast-specific soft-
ware, contrast agents offer real-time dynamic contrast-
enhanced sonographic evaluation.7-12 CEUS has gained
clinical recognition for a variety of imaging applica-
tions.7-11 In cardiology, CEUS is used to improve the
accuracy of echocardiograms and to facilitate the evaluation
of myocardial perfusion.12 In body imaging, CEUS is used
to detect and characterize focal parenchymal pathology and
to assess inflammatory activity in Crohn’s disease.7,11 Vas-
Fig 1. Angiographic images of the left kidney with the c
saccular aneurysm (arrow) originating at the bifurcation o
(B) shows a dense Gugliemi Detachable Coil (GDC) mas
is identified; there is no residual neck demonstrated. Th
normal parenchymal enhancement of the kidney.
Fig 2. Corresponding sagittal grayscale (A) and color
aneurysm (arrow) as an echogenic focal area associated w
seen in the renal artery (arrow), but the coil material precular indications include assessment of vessel patency in tndeterminate cases on color Doppler ultrasound scans,
etection of acute vascular extravasation, and traumatic
evitalized parenchyma devoid of perfusion.7,10,11 CEUS
as rarely been used to monitor renal artery pseudoaneu-
ysms that have developed secondary to trauma or sur-
ery.13,14 After endovascular abdominal aortic aneurysm
epair (EVAR), CEUS is used to monitor grafts for en-
oleaks.15-17 A study of 108 patients that underwent
VAR found that CEUS was superior to standard ultra-
ound scan and similar to CT and MRI in detecting en-
oleaks.17 The authors concluded that CEUS may be a
easible tool for the long-term surveillance after EVAR, and
t may better classify endoleaks missed by other imaging
r tip in the main renal artery.A,Demonstrates a 1.5-cm
wer pole branch of the renal artery. Posttreatment image
in the aneurysm sac. No contrast filling of the aneurysm
in renal artery and its branches are patent, and there is
pler scan (B) images of the left kidney. A, Shows the
ense posterior acoustic shadowing. In (B), blood flow is
assessment of the aneurysm.athete
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Volume 54, Number 6 Low et al 1803CEUS has several limitations. CEUS requires contrast-
specific ultrasound software and ultrasound contrast agents
as a basic requirement to perform the procedure. The
ultrasound-specific contrast software is not available as a
standard application on most commercial ultrasound plat-
forms and needs to be purchased as an upgrade. Ultrasound
contrast agents are also generally more expensive than
standard CT or MRI contrast media. However, studies
suggest that CEUS is a cost-effective technique due to
improvements in diagnostic quality compared to standard
ultrasound scan and a reduction in the number of cases
referred for further investigations.18,19 Due to the operator-
dependent nature of the technique, CEUS is associated
with a learning curve, and so new practitioners require
appropriate training and supervision. Clinical use of CEUS
is dependent on regulatory approval by licensing bodies.
Widely employed in Asia, Europe, and Canada, CEUS has
not received Food & Drug Administration approval in the
United States for noncardiac use. Contraindications to
CEUS include known hypersensitivity to ultrasound con-
trast agents, left-to-right or bidirectional cardiac shunts,
intra-arterial administration, and use in pregnant women
and children. In general, ultrasound contrast agents are
well tolerated and have an excellent safety profile with a
severe event rate of 1:10,000 and an anaphylactoid reac-
tion rate lower than that of CT contrast agents (0.014%,
ultrasound contrast agents vs 0.034%-0.095%, CT).7 A
retrospective review of European experience with the use of
CEUS in more than 23,000 patients reported only two
serious adverse events and no deaths.20
To our knowledge, this is the first reported account of
Fig 3. Corresponding sagittal contrast-enhanced ultraso
left kidney. A, Shows no contrast filling of the aneurysm
arrow), and uniform enhancement of the renal parenc
duration) contrast-enhanced interrogation using multi
returning echo signal by a factor of 500 to 1000 times
limitations of standard and color Doppler scan.the use of CEUS in the surveillance of a coiled renal arteryneurysm. CEUS offers a suitable alternative to standard
maging modalities. Unlike CT or MRI, CEUS is not
ssociated with risk of nephrotoxicity or nephrogenic sys-
emic fibrosis. CEUS is helpful for problem solving in
ndeterminate cases on CT and MRI. While CT and MRI
cquire images as “snapshots” in time, CEUS acquires
mages continuously for 3 to 5 minutes with no loss of
emporal data. By reducing the need for downstream im-
ging tests, CEUS may also shorten the diagnostic workup
f patients.
ONCLUSION
We believe that we present the first case of contrast-
nhanced ultrasound surveillance of a coiled renal artery
neurysm. CEUS satisfies a clinical demand in cases where
tandard imaging modalities are not appropriate. Referring
hysicians should, therefore, be aware of its potential as a
iagnostic option.
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